Allurion Technologies (ALURD) Total Liabilities (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Total Liabilities came in at $91.9 million in Q1 2026, down 15.06% YoY from $108.2 million in Q1 2025, and down 1.14% on a QoQ basis from $93.0 million in Q4 2025.
Allurion Technologies (ALURD) Total Liabilities (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Total Liabilities data on file, last reported at $91.9 million in Q1 2026.
- Quarterly Total Liabilities fell 15.06% year-over-year to $91.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $91.9 million (down 15.06% YoY) and the FY2025 annual result came in at $93.0 million, down 16.09% from the prior year.
- Total Liabilities eased to $91.9 million in Q1 2026, from $93.0 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $173.4 million in Q3 2023 to a low of $83.7 million in Q4 2022.
- A 5-year average of $113.7 million and a median of $110.8 million in 2024 frame the typical range for Total Liabilities.
- Annual changes were most pronounced in 2023 — Total Liabilities soared 70.89% — and 2024, when it sank 33.98%.
- Tracing ALURD's Total Liabilities over 5 years: stood at $83.7 million in 2022, then soared by 70.89% to $143.0 million in 2023, then dropped by 22.53% to $110.8 million in 2024, then retreated by 16.09% to $93.0 million in 2025, then fell by 1.14% to $91.9 million in 2026.
- The last three Total Liabilities figures came in at $91.9 million (Q1 2026), $93.0 million (Q4 2025), and $101.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 109.22 Bn |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 23.94 Bn |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 42.96 Bn |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 45.22 Bn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 3.14 Bn |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 3.83 Bn |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 26.03 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 17.70 Bn |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 3.51 Bn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | 91.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.91 Mn |
| Dec 31, 2025 | 92.96 Mn |
| Sep 30, 2025 | 101.07 Mn |
| Jun 30, 2025 | 92.15 Mn |
| Mar 31, 2025 | 108.20 Mn |
| Dec 31, 2024 | 110.79 Mn |
| Sep 30, 2024 | 114.51 Mn |
| Jun 30, 2024 | 117.13 Mn |
| Mar 31, 2024 | 126.15 Mn |
| Dec 31, 2023 | 143.01 Mn |
| Sep 30, 2023 | 173.44 Mn |
| Jun 30, 2023 | 123.37 Mn |
| Dec 31, 2022 | 83.68 Mn |